Physicians Committee Encourages Clinicians to Consider Dietary Interventions for Type 2 Diabetes

Global Meta-Analysis Finds Vegetarian Diet Lowers HbA1c Levels by 0.4 Points
Dr. Neal Barnard posing for a portrait

WASHINGTON (Nov. 14, 2014) — A new global meta-analysis published in Cardiovascular Diagnosis and Therapy shows a plant-based vegetarian diet accelerates type 2 diabetes treatment by lowering HbA1c levels by 0.4 points.

Researchers with the Physicians Committee analyzed dietary patterns of 255 adults with type 2 diabetes in the United States, Brazil, and the Czech Republic. They find a low-fat vegan or lacto-ovo vegetarian diet lowers HbA1c by an average of 0.4 percentage points and up to 0.7 points in some studies, comparable to the same effect of alpha-glucosidase inhibitors.

“Plant-based diets work in a different way than ‘conventional’ diabetes diets,” says Neal Barnard, M.D., of the George Washington University School of Medicine and Health Sciences and one of the study authors. “We now know that type 2 diabetes is caused by insulin resistance. Getting the animal fat—and fats in general—out of the diet helps repair insulin’s ability to function.”  

The American Diabetes Association’s Clinical Practice Recommendations have cited the value of vegan diets for type 2 diabetes for several years. The new study results will give more confidence to doctors who aim to reduce their patients’ need for medications. Currently, more than 100 million Americans have either diabetes or prediabetes.

“A diet change beats a pill,” says registered dietitian Susan Levin, M.S., R.D., also a study author. “A plant-based diet improves blood sugar, body weight, blood pressure, and cholesterol all at the same time, something no drug can do.”

Adults with diabetes have a 2-4 times higher risk for heart disease or stroke, compared to those without diabetes. If current trends continue, one in three children born today will develop type 2 diabetes at some point in his or her life.

###

This Press Releases posted courtesy of the Physicians Committee for Responsible Medicine.

Latest News

The Center for Faculty Excellence recently named six faculty members from the George Washington University School of Medicine and Health Sciences as the newest cohort of members to the Academy of Education Scholars.
Daniel S. Carrero, MD, was officially installed as the inaugural Seymour and Ruth Perlin Professor of Psychiatry and Behavioral Health in the School of Medicine and Health Sciences (SMHS) during a ceremony Oct. 18 in the Jack Morton Auditorium at the George Washington University.
ANNOUNCEMENT (Oct. 15, 2024) - William “Bill” Elliott has been appointed as CEO of the GW Medical Faculty Associates, the faculty practice organization that hosts the clinical practices of the George Washington University School of Medicine and Health Sciences (SMHS).